Data Safety Monitoring Board Approves Third Cohort in Advanced Cell Technology Clinical Trials

The Data Safety Monitoring Board has given Advanced Cell Technology approval to treat patients in the third cohort of each of the company’s three stem cell clinical trials, according to a report by the Fort Mill Times.

Advertisement
Carrie Pallardy

Advanced Cell Technology, a Santa Monica, Calif.-based regenerative medicine company, is also working towards a macular degeneration treatment in two clinical trials recently approved by the FDA.

More Articles on Ophthalmology:
EyeTechCare Receives $13M in Funding
10 Statistics on Ophthalmologist Compensation by Location
Dr. Andrew Holzman to Participate in FDA Trial

What payers should demand from AI-enabled primary care

Recommended Live Webinar on Mar 10, 2026 1:00 PM - 2:00 PM CST

Advertisement

Next Up in Ophthalmology

  • Montana physician practice acquired 

    Southlake, Texas-based Retina Consultants of America has acquired Montana Retina Consultants, according to a Feb. 5 news release.  Bozeman-based Montana…

    By: Patsy Newitt

  • Louisiana ophthalmology practice acquired 

    Vision Innovation Partners acquired Ophthalmic Associates of Alexandria (Va.), according to a Feb. 2 press release. Founded in 2010, Ophthalmic…

    By: Patsy Newitt

  • American Board of Ophthalmology names CEO

    The American Board of Ophthalmology has appointed Steven Gedde, MD, as its next CEO.  Dr. Gedde is an ophthalmologist and…

    By: Cameron Cortigiano
Advertisement

Comments are closed.